Angelucci, F., Nedelska, Z., Manová, B. N., Katonová, A., Jurášová, V., Svetlikova, D., . . . Hort, J. Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1). American Chemical Society.
Chicago Style (17th ed.) CitationAngelucci, Francesco, Zuzana Nedelska, Blanka Napravnikova Manová, Alžbeta Katonová, Vanesa Jurášová, Daniela Svetlikova, Martin Vyhnálek, and Jakub Hort. Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1). American Chemical Society.
MLA (9th ed.) CitationAngelucci, Francesco, et al. Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1). American Chemical Society.